Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...

Young athletes are being recruited to plug a staff shortage in Japan’s nursing homes. The results are reshaping elder care. By Chang W. Lee, Javier C. Hernández and Hisako Ueno Pablo on TKO’s rise and ...